How is this sort of thing legal?
What are the consequenses to the analyst if proven to be FOS and manipulating share price?
Will the company (INSM) make any statement?
Does anyone know exactly what went on at the presentation today?
Let's just hope the downgrades weren't because they didn't get a piece of some sort of dilutive financing coming down the pike. I'm puzzled that Mr. Lewis, a Wall St. insider himself, wasn't able to coddle and regularly keep the few analyst that cover us informed enough to prevent today's ridiculous analyst actions. ?!
Regardless, it's sleazy masquerade, all the way around.
IR mentioned that all the analysts have spoken to Insmed management within the last three weeks except Wedbush. They estimated the last time Wedbush communicated with Insmed management was almost a year ago.
Yeah a complaint to the SEC (sic) will do a lot of good. It is Wedbushs OPINION.It may be a slanted one, it may be an accurate one ...a Phase3 trial is a very real Possibility which is wht Insmed has 2018 as a possibility also.
That's the rub with this. It's first of all NOT legal. Secondly if an analyst is caught doing something like
this to manipulate a stock for any reason..(to help shorts cover, or to push shares out of retail hands) I don't
think the company can make a statement, and I thought the presentation was tomorrow.